Glutathione refills aren't about reordering the same product repeatedly
What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients
Policy The problem is that these claims often lack substantial data
Once the body produces GSH, it only works as an antioxidant in its active form, confusingly referred to as reduced-L-glutathione (GSH)
Dubinskaia ED, Gasparov AS, Fedorova TA, Lapteva NV
h , PRKAA1 mRNA levels in shCtrl and shYBX1 H1299 cells
